US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lantern Pharma Inc.

3.98

+0.12003.11%

Post-market: 3.980.00000.00%19:54 EDT

Volume:20.57K

Turnover:81.83K

Market Cap:42.92M

PE:-2.06

High:4.05

Open:3.91

Low:3.85

Close:3.86

Loading ...

Overview Company News Filings

Press Release: Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET

Lantern Advances Drug Candidate Lp-184 With Ind Clearance for Phase 1B/2 Clinical Trial in Triple Negative Breast Cancer (Tnbc)

THOMSON REUTERS

Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC)

EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial

Lantern Pharma Inc expected to post a loss of 49 cents a share - Earnings Preview

Lantern Pharma initiated with a Buy at Lake Street

LTRN: 2024 Financial Results

Zacks Small Cap Research

Lantern Pharma Inc Qtrly EPS $-0.54

Lantern Pharma Inc reports results for the quarter ended December 31 - Earnings Summary

Lantern Pharma Reports Q4 2024 Financial Results and AI Progress

Lantern Pharma Q4 2024 GAAP EPS $(0.54) Misses $(0.51) Estimate

Lantern Pharma Inc Qtrly EPS $-0.54

THOMSON REUTERS

Lantern Pharma reports Q4 EPS (54c) vs (39c) last year

Press Release: Lantern Pharma Provides Business Updates and Fourth Quarter & Year-End 2024 Financial Results

Press Release: Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27th, 2025 at 4:30 p.m. ET

Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27TH, 2025 at 4:30 P.m. Et

THOMSON REUTERS

LTRN: M&A Illuminates GBM Value

Zacks Small Cap Research

Lantern Pharma Announces PCT Patent Application Publication for Innovative, High Performing, Machine Learning Model for Predicting Blood Brain Barrier Permeability of Drug-Candidates

Lantern Pharma Inc. (LTRN) Enhances RADR® AI Platform to Accelerate Development of Antibody-Drug Conjugates (ADCs) for Targeted Cancer Therapies

Lantern Pharma : Announces Advancements in Application of Co's Radr AI Platform to Accelerate Development of Antibody-Drug Conjugates for Cancer

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LTRN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LTRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTRN\",,,,,undefined,":{"symbol":"LTRN","market":"US","secType":"STK","nameCN":"Lantern Pharma Inc.","latestPrice":3.98,"timestamp":1746820800000,"preClose":3.86,"halted":0,"volume":20571,"hourTrading":{"tag":"盘后","latestPrice":3.98,"preClose":3.98,"latestTime":"19:54 EDT","volume":74,"amount":282.114,"timestamp":1746834848156},"delay":0,"floatShares":7963676,"shares":10784725,"eps":-1.930923,"marketStatus":"Market Closed","change":0.12,"latestTime":"05-09 16:00:00 EDT","open":3.91,"high":4.05,"low":3.8522,"amount":81828.940681,"amplitude":0.051244,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.930923,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"listingDate":1591848000000,"exchange":"NASDAQ","adjPreClose":3.86,"preHourTrading":{"tag":"盘前","latestPrice":3.8599,"preClose":3.86,"latestTime":"08:59 EDT","volume":84,"amount":324.239194,"timestamp":1746795575689},"postHourTrading":{"tag":"盘后","latestPrice":3.98,"preClose":3.98,"latestTime":"19:54 EDT","volume":74,"amount":282.114,"timestamp":1746834848156},"volumeRatio":0.33440733048803173,"impliedVol":0.9042,"impliedVolPercentile":0.684},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTRN\",,,,,undefined,":{"symbol":"LTRN","floatShares":7963676,"roa":"-40.12%","roe":"-66.93%","lyrEps":-1.930923,"volumeRatio":0.33440733048803173,"shares":10784725,"dividePrice":0,"high":4.05,"amplitude":0.051244,"preClose":3.86,"low":3.8522,"week52Low":2.55,"pbRate":"2.03","week52High":6.81,"institutionHeld":0,"latestPrice":3.98,"eps":-1.930923,"divideRate":0,"volume":20571,"delay":0,"ttmEps":-1.930923,"open":3.91,"prevYearClose":3.19,"prevWeekClose":3.54,"prevMonthClose":3.52,"prevQuarterClose":3.54,"fiveDayClose":3.54,"twentyDayClose":3.04,"sixtyDayClose":4.81,"earningDate":1747238400000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LTRN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533182084","title":"Press Release: Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2533182084","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533182084?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:33","pubTimestamp":1746707580,"startTime":"0","endTime":"0","summary":"Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET. -- Webcast to be held Thursday, May 15th, 9:00 a.m. ET, register for the. webcast here, or at the link provided below.Lantern Pharma Inc. , an artificial intelligence  company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning  platform with multiple clinical stage drug programs, today announced that it will host its first quarter 2025 operating and financial results webcast on Thursday, May 15, 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time.Our lead development programs include a Phase 2 clinical program and multiple Phase 1 clinical trials. We have also established a wholly-owned subsidiary, Starlight Therapeutics, to focus exclusively on the clinical execution of our promising therapies for CNS and brain cancers, many of which have no effective treatment options. Our AI-driven pipeline of innovative product candidates i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","ET"],"gpt_icon":0},{"id":"2533581441","title":"Lantern Advances Drug Candidate Lp-184 With Ind Clearance for Phase 1B/2 Clinical Trial in Triple Negative Breast Cancer (Tnbc)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533581441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533581441?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:55","pubTimestamp":1746449700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA2MYFNL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2533399587","title":"Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533399587","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533399587?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:55","pubTimestamp":1746449700,"startTime":"0","endTime":"0","summary":"Figure 1: Preclinical PDX Tumor Models & LP-184 Tumor Volume Change. Figure 2: LP-184 Synergy with Olaparib in Treatment Resistant TNBC PDX Models.The FDA has cleared the investigational new drug  application of LP-184 in triple negative breast cancer  treatment – a novel small molecule advanced and developed with Lantern’s AI platform, RADR. The phase 1b/2 clinical trial plans to evaluate LP-184 in recurrent TNBC patients as both monotherapy and in combination with olaparib.This achievement follows the FDA’s Orphan Drug Designation for LP-184 in TNBC in 2023 and FDA Fast Track Designation for LP-184 in TNBC in 2024.DALLAS, May 05, 2025----Lantern Pharma Inc. , an artificial intelligence company developing targeted and transformative cancer therapies using its proprietary AI platform, RADR, today announced that it has received clearance of its Investigational New Drug Application  from the U.S. Food and Drug Administration  for a Phase 1b/2 clinical trial for LP-184 in Triple Negative ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-advances-drug-candidate-lp-125500305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4231","LTRN","ADC","BK4139","BK4080"],"gpt_icon":0},{"id":"2533873125","title":"EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2533873125","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533873125?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:31","pubTimestamp":1746448308,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration  on Monday cleared Lantern Pharma Inc.’s  Investigational New Drug Application  for a Phase 1b/2 trial for LP-184 in triple-negative breast cancer .Monotherapy Arm: An open-label study involving approximately 30 patients with advanced-stage TNBC, focusing on dose optimization to evaluate, enhance, and optimize safety and potential efficacy for TNBC patients.Combination Therapy: Evaluation of LP-184 in combination with olaparib in second-line settings for patients with advanced-stage TNBC harboring BRCA1 or BRCA2 alterations, with primary endpoints including safety and efficacy parameters that could support a pathway to regulatory approval.In preclinical studies, treating an animal model with BRCA-1 LOH and an HRD score of 63 resistant to the PARP inhibitor showed evidence of resensitization in combination with LP-184.In 2024, LP-184 received Fast Track Designations from the FDA for GBM andTNBC.Dose levels 7, 8, and 9 were cleared without safety con","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-lantern-advances-breast-cancer-123148984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LTRN","SSI"],"gpt_icon":1},{"id":"2533043583","title":"Lantern Pharma Inc  expected to post a loss of 49 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533043583","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533043583?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:42","pubTimestamp":1746445325,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc  expected to post a loss of49cents a share - Earnings Preview Lantern Pharma Inc LTRN.OQ LTRN.O is expected to show no change in quarterly revenue when it reports  results on May 7 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL8N3RD0QI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2524249684","title":"Lantern Pharma initiated with a Buy at Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2524249684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524249684?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:47","pubTimestamp":1743598021,"startTime":"0","endTime":"0","summary":"Lake Street initiated coverage of Lantern Pharma (LTRN) with a Buy rating and $25 price target Lantern’s Response Algorithm for Drug Positioning an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lantern-pharma-initiated-with-a-buy-at-lake-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lantern-pharma-initiated-with-a-buy-at-lake-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2522501367","title":"LTRN: 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522501367","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522501367?lang=en_us&edition=fundamental","pubTime":"2025-03-28 18:20","pubTimestamp":1743157200,"startTime":"0","endTime":"0","summary":"Lantern Pharma, Inc  reports 2024 results highlighting several achievements including progress on its HARMONIC, LP-184 and LP-284 trials, a portfolio of expedited designations in multiple indications and advances in the RADR platform with modules that offer predictive algorithms for blood brain barrier  penetration and antibody drug conjugate  design.On March 27th, 2025, Lantern announced 2024 financial and operational results, filed its Form 10-K with the SEC and hosted a video webcast to review accomplishments. A slide deck was included to guide the discussion. In the financial sphere, Lantern generated no revenues in 2024 and incurred operating expense of $22.2 million, producing a net loss of  million or  per share.General & administrative expenses were $6.1 million, rising 2% from $6.0 million. Higher professional fees were partially offset by lower wage and benefit costs, a decrease in insurance expense and a decline in stock","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ltrn-2024-financial-results-102000980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","USAW.SI","TQQQ","QID","LTRN","CMRX","JAZZ","LU0109394709.USD","USJW.SI","SQQQ","IE00BN0W2W23.USD","BK4007","BK4080","LU0320765992.SGD","BK4583","ADC","NQmain","NVIW.SI","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK4231","MNQmain","LU0889565916.HKD",".IXIC","QLD","BK4139","BK4532","BK4533","LU0823416689.USD","TSYW.SI"],"gpt_icon":1},{"id":"2522309537","title":"Lantern Pharma Inc Qtrly EPS $-0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2522309537","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522309537?lang=en_us&edition=fundamental","pubTime":"2025-03-28 05:12","pubTimestamp":1743109969,"startTime":"0","endTime":"0","summary":"March 27 (Reuters) - Lantern Pharma Inc ::*LANTERN PHARMA INC QTRLY EPS $-0.54  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 27-MAR-202520:01:00.123 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nRSD9W4BY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2522321585","title":"Lantern Pharma Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522321585","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522321585?lang=en_us&edition=fundamental","pubTime":"2025-03-28 05:00","pubTimestamp":1743109253,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc reports results for the quarter ended December 31 - Earnings SummaryLantern Pharma Inc LTRN.OQ reported a quarterly adjusted loss of 54 cents per share for the quarter ended Decembe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA25D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2522534161","title":"Lantern Pharma Reports Q4 2024 Financial Results and AI Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2522534161","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522534161?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:35","pubTimestamp":1743107722,"startTime":"0","endTime":"0","summary":"Lantern Pharma ( ($LTRN) ) has issued an announcement. On March 27, 2025, Lantern Pharma announced its financial results for the fourth quarter and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lantern-pharma-reports-q4-2024-financial-results-and-ai-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lantern-pharma-reports-q4-2024-financial-results-and-ai-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065732104.USD","BK4139","PRGS","LTRN","BK4097"],"gpt_icon":0},{"id":"2522312455","title":"Lantern Pharma Q4 2024 GAAP EPS $(0.54) Misses $(0.51) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522312455","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522312455?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:28","pubTimestamp":1743107339,"startTime":"0","endTime":"0","summary":"Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.51) by 5.88 percent. This is a 38.46 percent decrease over losses of $(0.39) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44524498/lantern-pharma-q4-2024-gaap-eps-0-54-misses-0-51-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN"],"gpt_icon":0},{"id":"2522531388","title":"Lantern Pharma Inc Qtrly EPS $-0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2522531388","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522531388?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:18","pubTimestamp":1743106711,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA1MY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2522853160","title":"Lantern Pharma reports Q4 EPS (54c) vs (39c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2522853160","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522853160?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:06","pubTimestamp":1743105964,"startTime":"0","endTime":"0","summary":"“With three clinical precision oncology programs actively enrolling patients and critical data milestones on the horizon, we are at the forefront o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lantern-pharma-reports-q4-eps-54c-vs-39c-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lantern-pharma-reports-q4-eps-54c-vs-39c-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LTRN"],"gpt_icon":0},{"id":"2522365539","title":"Press Release: Lantern Pharma Provides Business Updates and Fourth Quarter & Year-End 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522365539","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522365539?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:01","pubTimestamp":1743105660,"startTime":"0","endTime":"0","summary":"-- HARMONIC trial lead-in cohort delivered impressive 86% clinical. benefit rate and 43% objective response rate in never-smoker NSCLC. patients, with current expansion cohort reinforcing these positive trends. as enrollment accelerates in Japan and Taiwan, where 33-40% of NSCLC. cases occur in never-smokers, positioning Lantern for multiple clinical. -- LP-184 received two U.S. FDA Fast Track Designations in 2024 for. Glioblastoma and Triple Negative Breast Cancer, plus three additional. potential across multiple high-need indications with multi billion U.S.-- Successfully dosed multiple patient cohorts in Phase 1A clinical trials. for both LP-184 and LP-284, advancing these synthetic lethal drug. candidates toward drug concentration levels that may show therapeutic. efficacy in several cancers of high unmet patient need and with multiple. immunologically \"cold\" tumors into \"hot\" tumors by reshaping the tumor. Scientific Advisory Board from Johns Hopkins, UCSF, and Memorial Sloan. pro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4604","BK4588","ML","03160","BK4139","BK4166","LTRN","BK4585","R","TM","BK4232","BK4555","BK4022"],"gpt_icon":0},{"id":"2520537134","title":"Press Release: Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27th, 2025 at 4:30 p.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2520537134","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520537134?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:02","pubTimestamp":1742472120,"startTime":"0","endTime":"0","summary":"Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27th, 2025 at 4:30 p.m. ET. -- Webcast to be held Thursday, March 27th, 4:30 p.m. ET, register for the. webcast here, or at the link provided below.Lantern Pharma Inc. , an artificial intelligence  company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning  platform with multiple clinical stage drug programs, today announced that it will host its fourth quarter and fiscal year 2024 operating and financial results webcast on Thursday, March 27, 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time.Our lead development programs include a Phase 2 clinical program and multiple Phase 1 clinical trials. We have also established a wholly-owned subsidiary, Starlight Therapeutics, to focus exclusively on the clinical execution of our promising therapies for CNS and brain cancers, many of which have no effective treatment options. Our AI-driven pip","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ET","LTRN"],"gpt_icon":0},{"id":"2520453183","title":"Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27TH, 2025 at 4:30 P.m. Et","url":"https://stock-news.laohu8.com/highlight/detail?id=2520453183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520453183?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:00","pubTimestamp":1742472003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA2CF2GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2518010224","title":"LTRN: M&A Illuminates GBM Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2518010224","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518010224?lang=en_us&edition=fundamental","pubTime":"2025-03-10 17:28","pubTimestamp":1741598880,"startTime":"0","endTime":"0","summary":"Lantern Pharma, Inc  continues to enroll its HARMONIC trial for LP-300 at sites around the globe with the most recent focus on Taiwan and Japan, where the prevalence of never-smoker non-small cell lung cancer  is from two to three times higher than in the United States. Lantern’s RADR  platform continues to break ground with new capabilities in predicting blood brain barrier  permeability of drug candidates and improving the development of antibody drug conjugate  design. Lantern’s LP-184 gains another Fast Track designation for triple negative breast cancer  following the receipt of the same designation for glioblastoma last October. The company also angled a spotlight towards its STAR-001  program at the Society for Neuro-Oncology  2024 conference. The associated poster provided support for the combination of spironolactone with the next-generation acylfulvene in glioblastoma multiforme  and clarified the path forward for STAR-001 with the candidate’s trial design. GBM also made an a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ltrn-m-illuminates-gbm-value-092800196.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","BK4583","IE00BN0W2W23.USD","SQQQ","BK4135","BK4007","BK4080","BK4231",".IXIC","IE00BN0W2T93.GBP","BK4139","MNQmain","BK4090","LU0320765992.SGD","USAW.SI","PCT","ADC","QLD","NVIW.SI","TSYW.SI","LU0823416689.USD","QID","LTRN","IE00BN0W2V16.EUR","LU0109394709.USD","NQmain","TQQQ","JAZZ","CNS","USJW.SI","CMRX","PSQ","BK4533","QQQ","LU0889565916.HKD"],"gpt_icon":0},{"id":"2512040061","title":"Lantern Pharma Announces PCT Patent Application Publication for Innovative, High Performing, Machine Learning Model for Predicting Blood Brain Barrier Permeability of Drug-Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2512040061","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512040061?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970000,"startTime":"0","endTime":"0","summary":"DALLAS, February 19, 2025----Lantern Pharma Inc. , an artificial intelligence  company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development, today announced the publication of its PCT patent application  covering a novel machine learning solution for predicting blood-brain barrier  permeability. The application received a favorable PCT search report indicating no significant prior art, substantially strengthening its path to approval.Lantern's wholly-owned subsidiary, Starlight Therapeutics, intends to implement this technology to advance the development of STAR-001 and evaluate additional drug candidates. In addition, Lantern is actively expanding the system's capabilities through the development of soph","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-pharma-announces-pct-patent-130000045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4090","BK4139","BK4080","LTRN","BK4231","BK4166","PCT","ADC","ML"],"gpt_icon":0},{"id":"2506558534","title":"Lantern Pharma Inc. (LTRN) Enhances RADR® AI Platform to Accelerate Development of Antibody-Drug Conjugates (ADCs) for Targeted Cancer Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2506558534","media":"Insider Monkey","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506558534?lang=en_us&edition=fundamental","pubTime":"2025-01-28 07:54","pubTimestamp":1738022099,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the Top 10 AI Stocks Dominating Wall Street.In this article, we are going to take a look at where Lantern Pharma Inc.  stands against the other AI stocks.The artificial intelligence community is raving over a new reasoning model that has surprised even Silicon Valley. Developed by Chinese start-up DeepSeek, the r1 claims to match and even exceed OpenAI’s o1 by multiple benchmarks, and that too, at a fraction of the cost. A Chinese hedge-fund manager, Liang Wenfeng, has led the development of r1. Wenfeng has become the leading figure in the country’s AI initiative.While some specialists are saying that DeepSeek’s technology is a bit behind OpenAI and Google, it is still an achievement considering it has used fewer and less advanced chips. The country has also had to deal with US restrictions along the way, implying how DeepSeek either found a way around the rules or the controls weren’t stringent enough in the first place.Why are we interested in the stock","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantern-pharma-inc-ltrn-enhances-235459932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2756315318.SGD","LU2462157665.USD","LU1674673691.USD","LU0444971666.USD","LU0107464264.USD","LU0149725797.USD","LU1145028129.USD","IE00B1BXHZ80.USD","LU1917777945.USD","IE00BJLML261.HKD","LU0345770308.USD","LU1670628061.USD","LU0128525689.USD","LU0557290698.USD","BK4514","SGXZ51526630.SGD","LU0345770993.USD","LU2111349929.HKD","LU1267930490.SGD","LU2456880835.USD","LU1244550221.USD","LU2362541513.USD","LU0348723411.USD","LU1989764664.SGD","LU0170899867.USD","LU0130517989.USD","BK4532","LU1066051811.HKD","LU1066051498.USD","GOOGL","LU2362540622.SGD","SG9999018857.SGD","LU1043141396.HKD","IE00BQXX3F31.USD","LU0345769128.USD","BK4538","LU0096362180.USD","LU0417517546.SGD","IE00BWXC8680.SGD","LU2592432038.USD","LU1988902786.USD","LU2092627202.USD","LU0211328371.USD","LTRN","LU0215105999.USD","LU2242649171.HKD","LU2242650005.HKD","RADR","LU0476273544.USD","AAQC"],"gpt_icon":1},{"id":"2506159371","title":"Lantern Pharma : Announces Advancements in Application of Co's Radr AI Platform to Accelerate Development of Antibody-Drug Conjugates for Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2506159371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506159371?lang=en_us&edition=fundamental","pubTime":"2025-01-27 20:57","pubTimestamp":1737982672,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3OL0GK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LTRN"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LTRN\",params:#limit:5,,,undefined,":[{"date":"2025-05-15","symbol":"LTRN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":null,"defaultRemindTime":1747296000000,"name":null,"time":"Pre-Market","dateTimestamp":1747281600000,"actualEps":null},{"market":"US","date":"2025-03-27","symbol":"LTRN","fiscalQuarterEnding":"2024/12","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2024-11-07","symbol":"LTRN","fiscalQuarterEnding":"2024/09","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.42},{"market":"US","date":"2024-08-08","symbol":"LTRN","fiscalQuarterEnding":"2024/06","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2024-05-09","symbol":"LTRN","fiscalQuarterEnding":"2024/03","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LTRN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LTRN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LTRN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LTRN","date":"2025-05-09","current":-2.003205,"percent":0.947151,"low":-49.754346,"twenty":-21.508432,"median":-4.127806,"eighty":-2.805336,"high":-1.33893,"avg":-10.69833,"sd":11.822395,"marketCap":41629038},"quantilePoints":[{"date":"2020-06-05","current":-39.359566,"twenty":-39.359566,"median":-39.359566,"eighty":-39.359566,"marketCap":96489504},{"date":"2020-06-12","current":-37.409733,"twenty":-39.359566,"median":-38.38465,"eighty":-36.899593,"marketCap":91709511},{"date":"2020-06-19","current":-33.224824,"twenty":-39.359566,"median":-36.899593,"eighty":-32.920529,"marketCap":81450258},{"date":"2020-06-26","current":-29.67408,"twenty":-38.579633,"median":-33.465813,"eighty":-30.394407,"marketCap":72745650},{"date":"2020-07-02","current":-33.300912,"twenty":-37.374225,"median":-33.123374,"eighty":-30.465455,"marketCap":81636786},{"date":"2020-07-10","current":-32.184964,"twenty":-37.165675,"median":-33.1741,"eighty":-30.790028,"marketCap":78901052},{"date":"2020-07-17","current":-33.478449,"twenty":-36.899593,"median":-32.933157,"eighty":-31.368191,"marketCap":82072016},{"date":"2020-07-24","current":-31.851447,"twenty":-36.261035,"median":-32.793662,"eighty":-31.345466,"marketCap":78083440},{"date":"2020-07-31","current":-28.842302,"twenty":-33.661132,"median":-32.540038,"eighty":-31.053798,"marketCap":76591222},{"date":"2020-08-07","current":-27.394157,"twenty":-33.453087,"median":-32.210326,"eighty":-29.81611,"marketCap":72745650},{"date":"2020-08-14","current":-25.240087,"twenty":-33.341492,"median":-32.077173,"eighty":-28.986296,"marketCap":67025480},{"date":"2020-08-21","current":-38.866924,"twenty":-33.661132,"median":-32.083514,"eighty":-28.857053,"marketCap":103211778},{"date":"2020-08-28","current":-39.967373,"twenty":-36.511038,"median":-32.223007,"eighty":-28.986296,"marketCap":106134039},{"date":"2020-09-04","current":-33.24761,"twenty":-36.899593,"median":-32.66685,"eighty":-29.267466,"marketCap":88289593},{"date":"2020-09-11","current":-45.04817,"twenty":-36.899593,"median":-32.793662,"eighty":-29.26828,"marketCap":119626181},{"date":"2020-09-18","current":-38.562545,"twenty":-38.866924,"median":-32.9712,"eighty":-29.290676,"marketCap":102403493},{"date":"2020-09-25","current":-42.987755,"twenty":-39.359566,"median":-33.224824,"eighty":-29.67408,"marketCap":114154713},{"date":"2020-10-02","current":-47.998076,"twenty":-39.382028,"median":-33.274261,"eighty":-30.384229,"marketCap":127459706},{"date":"2020-10-09","current":-47.085171,"twenty":-40.388822,"median":-33.478449,"eighty":-30.409674,"marketCap":125035473},{"date":"2020-10-16","current":-46.312516,"twenty":-41.770236,"median":-33.711344,"eighty":-30.688578,"marketCap":122983673},{"date":"2020-10-23","current":-40.974167,"twenty":-41.465857,"median":-34.558783,"eighty":-31.01829,"marketCap":108807597},{"date":"2020-10-30","current":-25.461466,"twenty":-41.442443,"median":-34.757801,"eighty":-30.688578,"marketCap":93885412},{"date":"2020-11-06","current":-27.569203,"twenty":-41.184891,"median":-33.715886,"eighty":-29.290676,"marketCap":101657383},{"date":"2020-11-13","current":-25.832427,"twenty":-40.974167,"median":-33.491805,"eighty":-28.916055,"marketCap":95253279},{"date":"2020-11-20","current":-27.063346,"twenty":-40.974167,"median":-33.300912,"eighty":-28.479745,"marketCap":99792110},{"date":"2020-11-27","current":-27.653512,"twenty":-40.974167,"median":-33.224824,"eighty":-27.569203,"marketCap":101968262},{"date":"2020-12-04","current":-25.798704,"twenty":-40.936705,"median":-33.098013,"eighty":-27.140684,"marketCap":95128928},{"date":"2020-12-11","current":-30.941582,"twenty":-40.496525,"median":-32.844388,"eighty":-26.678895,"marketCap":114092537},{"date":"2020-12-18","current":-31.44744,"twenty":-40.295167,"median":-32.692257,"eighty":-26.989154,"marketCap":115957811},{"date":"2020-12-24","current":-32.290534,"twenty":-40.229608,"median":-32.427759,"eighty":-27.12135,"marketCap":119066599},{"date":"2020-12-31","current":-32.459153,"twenty":-40.107856,"median":-32.526601,"eighty":-27.182053,"marketCap":119688357},{"date":"2021-01-08","current":-31.852125,"twenty":-39.901815,"median":-32.413226,"eighty":-27.286725,"marketCap":117450029},{"date":"2021-01-15","current":-24.179962,"twenty":-39.634897,"median":-32.24625,"eighty":-27.102015,"marketCap":89160054},{"date":"2021-01-22","current":-25.984185,"twenty":-39.377536,"median":-32.197645,"eighty":-26.635054,"marketCap":95812861},{"date":"2021-01-29","current":-25.343433,"twenty":-39.359566,"median":-32.083514,"eighty":-26.232054,"marketCap":93450182},{"date":"2021-02-05","current":-29.069912,"twenty":-39.359566,"median":-32.047625,"eighty":-26.206761,"marketCap":107191027},{"date":"2021-02-12","current":-31.127064,"twenty":-39.359566,"median":-32.037606,"eighty":-26.232054,"marketCap":114776471},{"date":"2021-02-19","current":-32.526601,"twenty":-39.359566,"median":-31.852125,"eighty":-26.279268,"marketCap":119937060},{"date":"2021-02-26","current":-29.963593,"twenty":-39.007407,"median":-31.641351,"eighty":-26.504432,"marketCap":110486343},{"date":"2021-03-05","current":-25.208537,"twenty":-38.866924,"median":-31.436771,"eighty":-26.279268,"marketCap":92952776},{"date":"2021-03-12","current":-35.863529,"twenty":-38.866924,"median":-31.442106,"eighty":-26.279268,"marketCap":211888545},{"date":"2021-03-19","current":-40.230675,"twenty":-39.007407,"median":-31.835263,"eighty":-26.504432,"marketCap":237690471},{"date":"2021-03-26","current":-35.371989,"twenty":-39.007407,"median":-31.868987,"eighty":-26.523765,"marketCap":208984432},{"date":"2021-04-01","current":-37.602825,"twenty":-38.895021,"median":-32.047625,"eighty":-26.523765,"marketCap":222164636},{"date":"2021-04-09","current":-32.381247,"twenty":-38.866924,"median":-32.083514,"eighty":-26.604703,"marketCap":191314558},{"date":"2021-04-16","current":-29.258566,"twenty":-38.866924,"median":-32.047625,"eighty":-26.665406,"marketCap":172865170},{"date":"2021-04-23","current":-31.321428,"twenty":-38.698345,"median":-31.852125,"eighty":-26.689012,"marketCap":185052947},{"date":"2021-04-30","current":-28.406926,"twenty":-38.581276,"median":-31.656371,"eighty":-26.894727,"marketCap":167833519},{"date":"2021-05-07","current":-22.155216,"twenty":-38.248499,"median":-31.436771,"eighty":-26.523765,"marketCap":174654202},{"date":"2021-05-14","current":-18.353937,"twenty":-37.716257,"median":-31.351316,"eighty":-26.216879,"marketCap":144687924},{"date":"2021-05-21","current":-20.552438,"twenty":-37.508972,"median":-31.195828,"eighty":-26.149432,"marketCap":162019167},{"date":"2021-05-28","current":-21.446023,"twenty":-37.424888,"median":-31.101771,"eighty":-26.017909,"marketCap":169063478},{"date":"2021-06-04","current":-21.524034,"twenty":-37.366783,"median":-31.022091,"eighty":-25.930125,"marketCap":169678458},{"date":"2021-06-11","current":-22.098481,"twenty":-37.274577,"median":-30.941582,"eighty":-25.818938,"marketCap":174206944},{"date":"2021-06-18","current":-21.403471,"twenty":-37.227708,"median":-30.614831,"eighty":-25.738872,"marketCap":168728035},{"date":"2021-06-25","current":-21.644597,"twenty":-37.029643,"median":-30.431937,"eighty":-25.62334,"marketCap":170628881},{"date":"2021-07-02","current":-20.708461,"twenty":-36.899593,"median":-30.384684,"eighty":-25.476146,"marketCap":163249126},{"date":"2021-07-09","current":-20.33968,"twenty":-36.890456,"median":-30.352795,"eighty":-25.221157,"marketCap":160341949},{"date":"2021-07-16","current":-18.439041,"twenty":-36.864694,"median":-30.182797,"eighty":-24.793735,"marketCap":145358811},{"date":"2021-07-23","current":-19.531199,"twenty":-36.581934,"median":-30.078022,"eighty":-22.705551,"marketCap":153968525},{"date":"2021-07-30","current":-15.403585,"twenty":-36.105763,"median":-29.947911,"eighty":-22.138196,"marketCap":144274103},{"date":"2021-08-06","current":-16.346905,"twenty":-35.960314,"median":-29.731278,"eighty":-21.726863,"marketCap":153109493},{"date":"2021-08-13","current":-15.045362,"twenty":-35.897559,"median":-29.424012,"eighty":-21.566586,"marketCap":140918891},{"date":"2021-08-20","current":-13.636352,"twenty":-35.725617,"median":-29.281466,"eighty":-21.409145,"marketCap":127721725},{"date":"2021-08-27","current":-16.788713,"twenty":-35.490294,"median":-29.267262,"eighty":-21.278653,"marketCap":157247588},{"date":"2021-09-03","current":-16.955884,"twenty":-35.417362,"median":-29.086774,"eighty":-21.074405,"marketCap":158813353},{"date":"2021-09-10","current":-16.10809,"twenty":-35.363879,"median":-29.010896,"eighty":-20.824769,"marketCap":150872686},{"date":"2021-09-17","current":-14.125923,"twenty":-35.256515,"median":-28.916055,"eighty":-20.685767,"marketCap":132307181},{"date":"2021-09-24","current":-14.531909,"twenty":-34.881047,"median":-28.820644,"eighty":-20.50705,"marketCap":136109754},{"date":"2021-10-01","current":-12.776617,"twenty":-34.574126,"median":-28.611675,"eighty":-20.294292,"marketCap":119669217},{"date":"2021-10-08","current":-13.182603,"twenty":-34.544735,"median":-28.462884,"eighty":-19.760978,"marketCap":123471790},{"date":"2021-10-15","current":-11.952704,"twenty":-34.44971,"median":-27.952719,"eighty":-19.576588,"marketCap":111952230},{"date":"2021-10-22","current":-12.036289,"twenty":-34.275477,"median":-27.705292,"eighty":-19.20497,"marketCap":112735113},{"date":"2021-10-29","current":-12.191519,"twenty":-34.173387,"median":-27.569203,"eighty":-18.370958,"marketCap":114189038},{"date":"2021-11-05","current":-9.842875,"twenty":-33.997191,"median":-27.187561,"eighty":-17.888706,"marketCap":115346279},{"date":"2021-11-12","current":-9.308247,"twenty":-33.714069,"median":-26.945313,"eighty":-16.795878,"marketCap":109081108},{"date":"2021-11-19","current":-8.582681,"twenty":-33.666475,"median":-26.65023,"eighty":-16.497358,"marketCap":100578375},{"date":"2021-11-26","current":-8.554041,"twenty":-33.505162,"median":-26.523765,"eighty":-16.346905,"marketCap":100242741},{"date":"2021-12-03","current":-7.2843,"twenty":-33.504591,"median":-26.279268,"eighty":-15.928978,"marketCap":85362959},{"date":"2021-12-10","current":-7.704365,"twenty":-33.478449,"median":-26.194958,"eighty":-15.475229,"marketCap":90285594},{"date":"2021-12-17","current":-7.341582,"twenty":-33.351637,"median":-26.152804,"eighty":-15.105066,"marketCap":86034228},{"date":"2021-12-23","current":-6.978799,"twenty":-33.311057,"median":-26.11908,"eighty":-14.656093,"marketCap":81782861},{"date":"2021-12-31","current":-7.618442,"twenty":-33.25827,"median":-26.017909,"eighty":-14.381456,"marketCap":89278691},{"date":"2022-01-07","current":-6.711485,"twenty":-33.229381,"median":-25.950292,"eighty":-14.202344,"marketCap":78650276},{"date":"2022-01-14","current":-6.940611,"twenty":-33.224824,"median":-25.874582,"eighty":-13.674562,"marketCap":81335349},{"date":"2022-01-21","current":-5.842715,"twenty":-33.19439,"median":-25.815565,"eighty":-13.464405,"marketCap":68469372},{"date":"2022-01-28","current":-6.033654,"twenty":-33.082795,"median":-25.798704,"eighty":-13.165886,"marketCap":70706933},{"date":"2022-02-04","current":-6.434624,"twenty":-33.00801,"median":-25.714394,"eighty":-12.7599,"marketCap":75405812},{"date":"2022-02-11","current":-6.596922,"twenty":-32.951779,"median":-25.630085,"eighty":-12.36182,"marketCap":77307739},{"date":"2022-02-18","current":-6.377343,"twenty":-32.874823,"median":-25.571068,"eighty":-12.213013,"marketCap":74734544},{"date":"2022-02-25","current":-6.100482,"twenty":-32.824098,"median":-25.473699,"eighty":-12.067335,"marketCap":71490080},{"date":"2022-03-04","current":-5.346275,"twenty":-32.763263,"median":-25.240087,"eighty":-11.589705,"marketCap":62651713},{"date":"2022-03-11","current":-5.964441,"twenty":-32.697339,"median":-25.054193,"eighty":-9.89061,"marketCap":73738551},{"date":"2022-03-18","current":-6.06908,"twenty":-32.63773,"median":-24.78699,"eighty":-9.669121,"marketCap":75032210},{"date":"2022-03-25","current":-6.226039,"twenty":-32.56707,"median":-23.472542,"eighty":-9.273878,"marketCap":76972698},{"date":"2022-04-01","current":-6.304518,"twenty":-32.507746,"median":-22.665836,"eighty":-8.714429,"marketCap":77942942},{"date":"2022-04-08","current":-6.11268,"twenty":-32.47134,"median":-22.141033,"eighty":-8.309639,"marketCap":75571234},{"date":"2022-04-14","current":-5.99932,"twenty":-32.455781,"median":-21.970826,"eighty":-8.080514,"marketCap":74169771},{"date":"2022-04-22","current":-6.01676,"twenty":-32.436479,"median":-21.687148,"eighty":-7.763555,"marketCap":74385381},{"date":"2022-04-29","current":-5.22141,"twenty":-32.411349,"median":-21.637505,"eighty":-7.50388,"marketCap":64552444},{"date":"2022-05-06","current":-4.746858,"twenty":-32.399323,"median":-21.446023,"eighty":-7.295756,"marketCap":66610324},{"date":"2022-05-13","current":-4.515304,"twenty":-32.363104,"median":-21.410563,"eighty":-7.230838,"marketCap":63361039},{"date":"2022-05-20","current":-4.631081,"twenty":-32.283789,"median":-21.375103,"eighty":-7.138233,"marketCap":64985682},{"date":"2022-05-27","current":-4.330061,"twenty":-32.252586,"median":-21.21908,"eighty":-7.009349,"marketCap":60761612},{"date":"2022-06-03","current":-4.413883,"twenty":-32.235688,"median":-21.112702,"eighty":-6.91197,"marketCap":61937853},{"date":"2022-06-10","current":-4.160254,"twenty":-32.210326,"median":-21.03469,"eighty":-6.740126,"marketCap":58378804},{"date":"2022-06-17","current":-3.755035,"twenty":-32.184964,"median":-20.786473,"eighty":-6.654203,"marketCap":52692557},{"date":"2022-06-24","current":-3.890108,"twenty":-32.161504,"median":-20.708461,"eighty":-6.500434,"marketCap":54587972},{"date":"2022-07-01","current":-4.337779,"twenty":-32.115171,"median":-20.665909,"eighty":-6.423168,"marketCap":60869922},{"date":"2022-07-08","current":-4.468993,"twenty":-32.094937,"median":-20.552438,"eighty":-6.333427,"marketCap":62711183},{"date":"2022-07-15","current":-4.160254,"twenty":-32.085385,"median":-20.424784,"eighty":-6.243603,"marketCap":58378804},{"date":"2022-07-22","current":-3.897827,"twenty":-32.075905,"median":-20.282945,"eighty":-6.231271,"marketCap":54696282},{"date":"2022-07-29","current":-3.959574,"twenty":-32.062919,"median":-19.775871,"eighty":-6.154674,"marketCap":55562758},{"date":"2022-08-05","current":-4.214284,"twenty":-32.045621,"median":-19.71559,"eighty":-6.100482,"marketCap":59136970},{"date":"2022-08-12","current":-4.266648,"twenty":-31.946552,"median":-19.580843,"eighty":-6.074312,"marketCap":69155596},{"date":"2022-08-19","current":-3.742088,"twenty":-31.865615,"median":-19.531199,"eighty":-6.039432,"marketCap":60653303},{"date":"2022-08-26","current":-3.802295,"twenty":-31.851718,"median":-19.048947,"eighty":-6.008464,"marketCap":61629171},{"date":"2022-09-02","current":-3.474796,"twenty":-31.841737,"median":-18.439041,"eighty":-5.953459,"marketCap":56320924},{"date":"2022-09-09","current":-3.563002,"twenty":-31.692149,"median":-18.311386,"eighty":-5.923279,"marketCap":57750609},{"date":"2022-09-16","current":-3.347832,"twenty":-31.465463,"median":-17.956789,"eighty":-5.846534,"marketCap":54263044},{"date":"2022-09-23","current":-3.16741,"twenty":-31.443172,"median":-16.955884,"eighty":-5.814926,"marketCap":51338688},{"date":"2022-09-30","current":-3.194139,"twenty":-31.421553,"median":-16.681247,"eighty":-5.711562,"marketCap":51771926},{"date":"2022-10-07","current":-3.374561,"twenty":-31.391233,"median":-16.526016,"eighty":-5.645613,"marketCap":54696282},{"date":"2022-10-14","current":-3.214186,"twenty":-31.357051,"median":-16.382728,"eighty":-5.408473,"marketCap":52096855},{"date":"2022-10-21","current":-3.133998,"twenty":-31.322155,"median":-16.299142,"eighty":-5.121538,"marketCap":50797141},{"date":"2022-10-28","current":-2.873389,"twenty":-31.271188,"median":-15.95883,"eighty":-4.705178,"marketCap":46573072},{"date":"2022-11-04","current":-2.873389,"twenty":-31.195301,"median":-15.582696,"eighty":-4.573964,"marketCap":46573072},{"date":"2022-11-11","current":-3.53139,"twenty":-31.167532,"median":-15.439407,"eighty":-4.510673,"marketCap":50919517},{"date":"2022-11-18","current":-4.005756,"twenty":-31.10683,"median":-15.140888,"eighty":-4.48443,"marketCap":57759452},{"date":"2022-11-25","current":-3.802456,"twenty":-31.066361,"median":-15.045362,"eighty":-4.468993,"marketCap":54828052},{"date":"2022-12-02","current":-3.840104,"twenty":-31.024372,"median":-14.627435,"eighty":-4.414099,"marketCap":55370904},{"date":"2022-12-09","current":-3.960578,"twenty":-31.016438,"median":-14.424442,"eighty":-4.387177,"marketCap":57108030},{"date":"2022-12-16","current":-4.322,"twenty":-30.99554,"median":-14.299065,"eighty":-4.362479,"marketCap":62319409},{"date":"2022-12-23","current":-4.231644,"twenty":-30.890981,"median":-14.221449,"eighty":-4.331605,"marketCap":61016564},{"date":"2022-12-30","current":-4.547888,"twenty":-30.688578,"median":-13.958752,"eighty":-4.322,"marketCap":65576521},{"date":"2023-01-06","current":-4.178937,"twenty":-30.664948,"median":-13.684115,"eighty":-4.2961,"marketCap":60256572},{"date":"2023-01-13","current":-4.12623,"twenty":-30.588305,"median":-13.582618,"eighty":-4.228632,"marketCap":59496579},{"date":"2023-01-20","current":-3.9154,"twenty":-30.498766,"median":-13.278129,"eighty":-4.214284,"marketCap":56456608},{"date":"2023-01-27","current":-4.005756,"twenty":-30.439507,"median":-13.170662,"eighty":-4.193895,"marketCap":57759452},{"date":"2023-02-03","current":-4.299411,"twenty":-30.418579,"median":-12.901995,"eighty":-4.200454,"marketCap":61993698},{"date":"2023-02-10","current":-4.465062,"twenty":-30.394954,"median":-12.752735,"eighty":-4.206043,"marketCap":64382247},{"date":"2023-02-17","current":-4.103641,"twenty":-30.384593,"median":-12.472746,"eighty":-4.181621,"marketCap":59170868},{"date":"2023-02-24","current":-3.9154,"twenty":-30.377849,"median":-12.340779,"eighty":-4.153392,"marketCap":56456608},{"date":"2023-03-03","current":-4.171407,"twenty":-30.355891,"median":-12.227342,"eighty":-4.141289,"marketCap":60148001},{"date":"2023-03-10","current":-3.23766,"twenty":-30.329741,"median":-12.125845,"eighty":-4.12749,"marketCap":46684186},{"date":"2023-03-17","current":-3.576568,"twenty":-30.26415,"median":-12.036289,"eighty":-4.099206,"marketCap":51570940},{"date":"2023-03-24","current":-3.437568,"twenty":-30.176471,"median":-11.648214,"eighty":-4.081052,"marketCap":49019535},{"date":"2023-03-31","current":-3.677398,"twenty":-30.136702,"median":-11.200436,"eighty":-4.068388,"marketCap":52439503},{"date":"2023-04-06","current":-3.761149,"twenty":-30.085978,"median":-9.852422,"eighty":-4.059969,"marketCap":53633777},{"date":"2023-04-14","current":-3.844899,"twenty":-30.04453,"median":-9.709218,"eighty":-4.007326,"marketCap":54828052},{"date":"2023-04-21","current":-3.738308,"twenty":-29.963593,"median":-9.594655,"eighty":-3.990697,"marketCap":53308066},{"date":"2023-04-28","current":-3.631716,"twenty":-29.947911,"median":-9.308247,"eighty":-3.990448,"marketCap":51788080},{"date":"2023-05-05","current":-3.806831,"twenty":-29.920953,"median":-9.126856,"eighty":-3.962604,"marketCap":54285200},{"date":"2023-05-12","current":-4.178189,"twenty":-29.788476,"median":-8.668604,"eighty":-3.962604,"marketCap":58519445},{"date":"2023-05-19","current":-3.643318,"twenty":-29.67408,"median":-8.491986,"eighty":-3.960578,"marketCap":51028088},{"date":"2023-05-26","current":-3.674325,"twenty":-29.474597,"median":-8.219898,"eighty":-3.959574,"marketCap":51462369},{"date":"2023-06-02","current":-4.116175,"twenty":-29.434129,"median":-8.057601,"eighty":-3.958337,"marketCap":57650882},{"date":"2023-06-09","current":-4.255706,"twenty":-29.397638,"median":-7.857115,"eighty":-3.95332,"marketCap":59605149},{"date":"2023-06-16","current":-4.581279,"twenty":-29.31075,"median":-7.704365,"eighty":-3.958337,"marketCap":64165106},{"date":"2023-06-23","current":-4.13943,"twenty":-29.279623,"median":-7.618442,"eighty":-3.959574,"marketCap":57976593},{"date":"2023-06-30","current":-3.992147,"twenty":-29.270665,"median":-7.456145,"eighty":-3.959976,"marketCap":55913756},{"date":"2023-07-07","current":-3.96114,"twenty":-29.268076,"median":-7.341582,"eighty":-3.960578,"marketCap":55479474},{"date":"2023-07-14","current":-4.030905,"twenty":-29.265523,"median":-7.269979,"eighty":-3.959775,"marketCap":56456608},{"date":"2023-07-21","current":-3.643318,"twenty":-29.224208,"median":-7.227019,"eighty":-3.953116,"marketCap":51028088},{"date":"2023-07-28","current":-3.488284,"twenty":-29.086774,"median":-7.181671,"eighty":-3.941001,"marketCap":48856680},{"date":"2023-08-04","current":-3.658822,"twenty":-29.083402,"median":-7.083815,"eighty":-3.9154,"marketCap":51245228},{"date":"2023-08-11","current":-3.80683,"twenty":-29.046305,"median":-7.012213,"eighty":-3.903079,"marketCap":54285200},{"date":"2023-08-18","current":-3.285114,"twenty":-28.94887,"median":-6.940611,"eighty":-3.893814,"marketCap":46845562},{"date":"2023-08-25","current":-3.582375,"twenty":-28.93268,"median":-6.768766,"eighty":-3.88239,"marketCap":51084488},{"date":"2023-09-01","current":-3.445178,"twenty":-28.906358,"median":-6.740126,"eighty":-3.874911,"marketCap":49128060},{"date":"2023-09-08","current":-3.361335,"twenty":-28.867569,"median":-6.701938,"eighty":-3.859234,"marketCap":47932466},{"date":"2023-09-15","current":-3.193649,"twenty":-28.842302,"median":-6.625563,"eighty":-3.847634,"marketCap":45541277},{"date":"2023-09-22","current":-2.8659,"twenty":-28.816312,"median":-6.511,"eighty":-3.842981,"marketCap":40867590},{"date":"2023-09-29","current":-2.629616,"twenty":-28.728847,"median":-6.484585,"eighty":-3.822188,"marketCap":37498188},{"date":"2023-10-06","current":-2.416198,"twenty":-28.668005,"median":-6.453718,"eighty":-3.818334,"marketCap":34454856},{"date":"2023-10-13","current":-2.431442,"twenty":-28.608896,"median":-6.372569,"eighty":-3.808049,"marketCap":34672237},{"date":"2023-10-20","current":-2.355221,"twenty":-28.574172,"median":-6.310514,"eighty":-3.80683,"marketCap":33585333},{"date":"2023-10-27","current":-2.103693,"twenty":-28.526959,"median":-6.304518,"eighty":-3.802392,"marketCap":29998550},{"date":"2023-11-03","current":-2.088448,"twenty":-28.459511,"median":-6.243583,"eighty":-3.796462,"marketCap":29781169},{"date":"2023-11-10","current":-2.674822,"twenty":-28.422564,"median":-6.234759,"eighty":-3.786034,"marketCap":40541519},{"date":"2023-11-17","current":-2.760875,"twenty":-28.134402,"median":-6.215769,"eighty":-3.775032,"marketCap":41845804},{"date":"2023-11-24","current":-2.891389,"twenty":-27.886995,"median":-6.18163,"eighty":-3.764808,"marketCap":43823969},{"date":"2023-12-01","current":-2.832586,"twenty":-27.775873,"median":-6.121399,"eighty":-3.757481,"marketCap":42932708},{"date":"2023-12-08","current":-2.696335,"twenty":-27.715647,"median":-6.100482,"eighty":-3.742088,"marketCap":40867590},{"date":"2023-12-15","current":-2.976008,"twenty":-27.619788,"median":-6.08652,"eighty":-3.728574,"marketCap":45106516},{"date":"2023-12-22","current":-2.92581,"twenty":-27.569203,"median":-6.060914,"eighty":-3.710855,"marketCap":44345683},{"date":"2023-12-29","current":-3.148115,"twenty":-27.569203,"median":-6.04292,"eighty":-3.682077,"marketCap":47715085},{"date":"2024-01-05","current":-2.997521,"twenty":-27.464175,"median":-6.03856,"eighty":-3.676169,"marketCap":45432587},{"date":"2024-01-12","current":-2.897126,"twenty":-27.286725,"median":-6.01676,"eighty":-3.652498,"marketCap":43910921},{"date":"2024-01-19","current":-2.753704,"twenty":-27.193069,"median":-5.99932,"eighty":-3.636357,"marketCap":41737113},{"date":"2024-01-26","current":-3.004693,"twenty":-27.12135,"median":-5.960859,"eighty":-3.595258,"marketCap":45541277},{"date":"2024-02-02","current":-3.033377,"twenty":-27.016133,"median":-5.947001,"eighty":-3.581467,"marketCap":45976039},{"date":"2024-02-09","current":-2.976008,"twenty":-26.844141,"median":-5.899997,"eighty":-3.557152,"marketCap":45106516},{"date":"2024-02-16","current":-2.875613,"twenty":-26.68564,"median":-5.852262,"eighty":-3.548697,"marketCap":43584850},{"date":"2024-02-23","current":-2.775217,"twenty":-26.665406,"median":-5.842715,"eighty":-3.544265,"marketCap":42063184},{"date":"2024-03-01","current":-3.449301,"twenty":-26.604703,"median":-5.815138,"eighty":-3.535733,"marketCap":52280082},{"date":"2024-03-08","current":-4.768784,"twenty":-26.523765,"median":-5.720282,"eighty":-3.534794,"marketCap":72279116},{"date":"2024-03-15","current":-5.270761,"twenty":-26.519898,"median":-5.711562,"eighty":-3.534822,"marketCap":79887444},{"date":"2024-03-22","current":-6.076744,"twenty":-26.459399,"median":-5.720282,"eighty":-3.535733,"marketCap":96994155},{"date":"2024-03-28","current":-6.581457,"twenty":-26.279268,"median":-5.814075,"eighty":-3.53892,"marketCap":105050148},{"date":"2024-04-05","current":-4.858703,"twenty":-26.220251,"median":-5.815247,"eighty":-3.540353,"marketCap":77552359},{"date":"2024-04-12","current":-4.488581,"twenty":-26.203389,"median":-5.798762,"eighty":-3.544265,"marketCap":71644631},{"date":"2024-04-19","current":-3.882925,"twenty":-26.186527,"median":-5.711562,"eighty":-3.544265,"marketCap":61977439},{"date":"2024-04-26","current":-3.67431,"twenty":-26.152804,"median":-5.676682,"eighty":-3.547966,"marketCap":58647629},{"date":"2024-05-03","current":-3.700511,"twenty":-26.152804,"median":-5.592109,"eighty":-3.544265,"marketCap":59065839},{"date":"2024-05-10","current":-4.590252,"twenty":-26.135942,"median":-5.449964,"eighty":-3.547966,"marketCap":73267462},{"date":"2024-05-17","current":-3.767359,"twenty":-26.11908,"median":-5.375831,"eighty":-3.548301,"marketCap":66059062},{"date":"2024-05-24","current":-3.822581,"twenty":-26.102218,"median":-5.270761,"eighty":-3.54929,"marketCap":67027355},{"date":"2024-05-31","current":-3.865532,"twenty":-26.034771,"median":-5.222097,"eighty":-3.551368,"marketCap":67780471},{"date":"2024-06-07","current":-3.564879,"twenty":-26.017909,"median":-5.215024,"eighty":-3.554841,"marketCap":62508657},{"date":"2024-06-14","current":-3.337856,"twenty":-25.997675,"median":-5.047678,"eighty":-3.548167,"marketCap":58527899},{"date":"2024-06-21","current":-2.724279,"twenty":-25.970628,"median":-4.921059,"eighty":-3.541918,"marketCap":47769094},{"date":"2024-06-28","current":-2.785637,"twenty":-25.957071,"median":-4.879965,"eighty":-3.538123,"marketCap":48844974},{"date":"2024-07-05","current":-2.632243,"twenty":-25.920042,"median":-4.773258,"eighty":-3.534794,"marketCap":46155273},{"date":"2024-07-12","current":-2.577021,"twenty":-25.889758,"median":-4.677392,"eighty":-3.524417,"marketCap":45186981},{"date":"2024-07-15","current":-2.712008,"twenty":-25.886385,"median":-4.672877,"eighty":-3.516764,"marketCap":47553918},{"date":"2024-08-02","current":-2.49112,"twenty":-25.883013,"median":-4.668362,"eighty":-3.513777,"marketCap":43680748},{"date":"2024-08-09","current":-2.595428,"twenty":-25.866151,"median":-4.656049,"eighty":-3.486212,"marketCap":45509745},{"date":"2024-08-16","current":-2.602067,"twenty":-25.832427,"median":-4.631081,"eighty":-3.47183,"marketCap":46180670},{"date":"2024-08-23","current":-2.559609,"twenty":-25.798704,"median":-4.597393,"eighty":-3.454749,"marketCap":45427139},{"date":"2024-08-30","current":-2.450431,"twenty":-25.798704,"median":-4.580911,"eighty":-3.437634,"marketCap":43489489},{"date":"2024-09-06","current":-2.122898,"twenty":-25.798704,"median":-4.569333,"eighty":-3.425531,"marketCap":37676537},{"date":"2024-09-13","current":-2.298796,"twenty":-25.763894,"median":-4.550892,"eighty":-3.410889,"marketCap":40798307},{"date":"2024-09-20","current":-2.468628,"twenty":-25.722553,"median":-4.532829,"eighty":-3.385253,"marketCap":43812430},{"date":"2024-09-27","current":-2.329123,"twenty":-25.714394,"median":-4.518517,"eighty":-3.364857,"marketCap":41336544},{"date":"2024-10-04","current":-2.183553,"twenty":-25.660436,"median":-4.507586,"eighty":-3.349575,"marketCap":38753010},{"date":"2024-10-11","current":-2.056179,"twenty":-25.633457,"median":-4.492149,"eighty":-3.345103,"marketCap":36492417},{"date":"2024-10-18","current":-2.056179,"twenty":-25.616595,"median":-4.48443,"eighty":-3.321099,"marketCap":36492417},{"date":"2024-10-25","current":-2.092571,"twenty":-25.586244,"median":-4.468993,"eighty":-3.300188,"marketCap":37138301},{"date":"2024-10-31","current":-1.977328,"twenty":-25.569382,"median":-4.468993,"eighty":-3.280799,"marketCap":35093003},{"date":"2024-11-08","current":-2.074375,"twenty":-25.516614,"median":-4.453556,"eighty":-3.262859,"marketCap":36815359},{"date":"2024-11-15","current":-1.967789,"twenty":-25.471252,"median":-4.414423,"eighty":-3.237626,"marketCap":37568890},{"date":"2024-11-22","current":-1.666407,"twenty":-25.390646,"median":-4.399527,"eighty":-3.221873,"marketCap":31814938},{"date":"2024-11-29","current":-1.813277,"twenty":-25.302095,"median":-4.397296,"eighty":-3.196812,"marketCap":34618967},{"date":"2024-12-06","current":-1.977093,"twenty":-25.227467,"median":-4.376411,"eighty":-3.174092,"marketCap":37746537},{"date":"2024-12-13","current":-2.050528,"twenty":-25.147834,"median":-4.367817,"eighty":-3.139645,"marketCap":39148551},{"date":"2024-12-20","current":-1.813277,"twenty":-25.05471,"median":-4.348356,"eighty":-3.094682,"marketCap":34618967},{"date":"2024-12-27","current":-1.988391,"twenty":-25.002055,"median":-4.337419,"eighty":-3.077838,"marketCap":37962232},{"date":"2025-01-03","current":-1.864117,"twenty":-24.803852,"median":-4.33356,"eighty":-3.053811,"marketCap":35589592},{"date":"2025-01-10","current":-2.214345,"twenty":-24.790362,"median":-4.324687,"eighty":-3.033377,"marketCap":42276122},{"date":"2025-01-17","current":-2.033582,"twenty":-24.530689,"median":-4.300154,"eighty":-3.018391,"marketCap":38825010},{"date":"2025-01-24","current":-2.355566,"twenty":-24.294623,"median":-4.299187,"eighty":-3.008996,"marketCap":44972303},{"date":"2025-01-31","current":-2.717091,"twenty":-23.331059,"median":-4.280286,"eighty":-3.000867,"marketCap":51874527},{"date":"2025-02-07","current":-2.993884,"twenty":-22.705551,"median":-4.269116,"eighty":-2.987482,"marketCap":57159042},{"date":"2025-02-14","current":-2.728389,"twenty":-22.665836,"median":-4.259678,"eighty":-2.976008,"marketCap":52090221},{"date":"2025-02-21","current":-2.445947,"twenty":-22.484282,"median":-4.247217,"eighty":-2.968837,"marketCap":46697859},{"date":"2025-02-28","current":-2.253886,"twenty":-22.189258,"median":-4.231644,"eighty":-2.952498,"marketCap":43031052},{"date":"2025-03-07","current":-2.197398,"twenty":-22.143869,"median":-4.214284,"eighty":-2.93585,"marketCap":41952580},{"date":"2025-03-14","current":-2.112666,"twenty":-22.115502,"median":-4.209055,"eighty":-2.92581,"marketCap":40334871},{"date":"2025-03-21","current":-2.101368,"twenty":-21.996357,"median":-4.192657,"eighty":-2.899677,"marketCap":40119177},{"date":"2025-03-28","current":-2.101368,"twenty":-21.820477,"median":-4.18341,"eighty":-2.890529,"marketCap":40119177},{"date":"2025-04-04","current":-1.686637,"twenty":-21.746721,"median":-4.174798,"eighty":-2.875613,"marketCap":35050356},{"date":"2025-04-11","current":-1.577654,"twenty":-21.675801,"median":-4.160254,"eighty":-2.868896,"marketCap":32785564},{"date":"2025-04-17","current":-1.811188,"twenty":-21.655944,"median":-4.145382,"eighty":-2.864249,"marketCap":37638690},{"date":"2025-04-25","current":-1.878654,"twenty":-21.64176,"median":-4.141289,"eighty":-2.848075,"marketCap":39040704},{"date":"2025-05-02","current":-1.878654,"twenty":-21.609137,"median":-4.13943,"eighty":-2.830572,"marketCap":39040704},{"date":"2025-05-09","current":-2.003205,"twenty":-21.508432,"median":-4.127806,"eighty":-2.805336,"marketCap":41629038}],"updateTime":1746921978066}}}